Production (Stage)
CARGO Therapeutics, Inc.
CRGX
$4.43
$0.061.37%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -135.96% | -41.64% | -18.15% | -148.42% | -180.94% |
| Total Depreciation and Amortization | -34.20% | 23.80% | 70.07% | 141.33% | 171.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 710.14% | 138.55% | -51.44% | 144.09% | 187.17% |
| Change in Net Operating Assets | 1,415.34% | 1,141.33% | -340.27% | 385.65% | 10,530.00% |
| Cash from Operations | -25.03% | -20.37% | -70.67% | -135.43% | -114.36% |
| Capital Expenditure | 70.36% | 75.93% | 70.47% | 2.01% | -129.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 112.10% | 8,194.96% | -14,060.87% | 525,500.00% | -504,498.28% |
| Cash from Investing | 111.92% | 1,050.54% | -1,005.84% | 353.75% | -47,388.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 46.15% | -99.90% | 6,600.00% | 5,167,350.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 89.69% | 100.00% | -- | -- |
| Cash from Financing | 136.54% | -100.05% | -99.11% | 5,167,350.00% | -100.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 99.19% | -101.96% | -558.50% | 539.53% | -669.85% |